AlphaStocks
6.1
Consider Buy

Certara, Inc. (CERT)

As of Sep 20, 2026, Certara, Inc. (CERT) scores 6.1/10 on AlphaStocks' five-model composite, #47 of 168 Health Care stocks. At $8.42, CERT trades 96% above its model fair value of $4.30.

Health Care / Health Care Technology

S&P SmallCap 600

$8.42

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#47out of 168 in Health Care

Is Certara, Inc. a Good Investment in 2026?

Certara, Inc. (CERT) scores 6.1 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Certara, Inc. as Attractive (5/9). However, the Greenblatt Magic Formula model rates it Caution — Earnings yield 1.8% · ROC 13%. Certara, Inc. currently trades 96% above its estimated fair value of $4.30. Certara, Inc. ranks #47 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-0.1Market Cap1B

Estimated Fair Value

$4.3096% above

Trading above estimated fair value — the market may be pricing in future growth.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Neutral

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Limited Data

Growth rate vs price (PEG)

Greenblatt

Caution

Earnings yield 1.8% · ROC 13%

Frequently Asked Questions

Is Certara, Inc. (CERT) a good investment?
As of Sep 20, 2026, Certara, Inc. (CERT) scores 6.1/10 on AlphaStocks' five-model composite, #47 of 168 Health Care stocks. At $8.42, CERT trades 96% above its model fair value of $4.30. That is a middle-of-the-pack score with no strong signal either way.
What is Certara, Inc.'s Piotroski F-Score?
Certara, Inc.'s Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is CERT overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $4.30, CERT appears overvalued. The stock currently trades 96% above its estimated fair value. Trading above estimated fair value — the market may be pricing in future growth.
How does CERT compare to other Health Care stocks?
Certara, Inc. ranks #47 out of 168 stocks in the Health Care sector, placing it in the top 28% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about CERT?
AlphaStocks evaluates CERT using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 6.1/10.

Similar Stocks

SOLVVEEVDOCS

Compare CERT with

CERT vs SOLVCERT vs VEEVCERT vs DOCS

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer